Macrogenics Inc (MGNX)

전일 마감가:

$15.22

열려 있는:

$15.64

하루 거래량:

610.62K

시가총액:

$980.32M

수익:

$56.91M

순이익/손실:

$-9.06M

주가수익비율:

130.58

EPS:

0.12

순현금흐름:

$-79.97M

1주 성능:

+7.62%

1개월 성능:

+14.63%

6개월 성능:

+195.10%

1년 성능:

+127.43%

1일 변동 폭

$15.32

$16.14

52주 변동 폭

$4.29

$21.88

Macrogenics Inc Stock (MGNX) Company Profile

명칭

Macrogenics Inc

부문

Healthcare (1213)

산업

Biotechnology (699)

전화

301-251-5172

주소

9704 Medical Center Drive, Rockville, MD

직원

330

트위터

@macrogenics

다음 수익 날짜

2024-05-09

최신 SEC 제출 서류

MGNX's Discussions on Twitter

Macrogenics Inc Stock (MGNX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2023-12-20	업그레이드	Citigroup	Neutral → Buy
2023-11-07	업그레이드	Guggenheim	Neutral → Buy
2023-03-17	다운그레이드	Guggenheim	Buy → Neutral
2022-11-22	다운그레이드	Cowen	Outperform → Market Perform
2022-11-14	업그레이드	BMO Capital Markets	Market Perform → Outperform
2022-07-18	다운그레이드	SMBC Nikko	Outperform → Neutral
2022-07-11	다운그레이드	BMO Capital Markets	Outperform → Market Perform
2022-05-04	다운그레이드	Guggenheim	Buy → Neutral
2022-02-28	업그레이드	Citigroup	Neutral → Buy
2022-02-11	개시	BMO Capital Markets	Outperform
2022-02-04	개시	SMBC Nikko	Outperform
2021-11-17	재개	Guggenheim	Buy
2021-10-19	개시	JMP Securities	Mkt Outperform
2021-10-15	재개	BTIG Research	Buy
2021-04-26	재개	Credit Suisse	Outperform
2021-03-12	업그레이드	Barclays	Underweight → Overweight
2020-12-22	재개	H.C. Wainwright	Buy
2020-08-03	다운그레이드	Citigroup	Buy → Neutral
2020-06-01	업그레이드	Guggenheim	Neutral → Buy
2020-05-26	재확인	H.C. Wainwright	Buy
2020-03-04	개시	Barclays	Underweight
2019-12-19	개시	Cantor Fitzgerald	Overweight
2019-12-18	개시	Cantor Fitzgerald	Overweight
2019-11-21	다운그레이드	Morgan Stanley	Equal-Weight → Underweight
2019-11-20	재개	Guggenheim	Neutral
2019-05-03	업그레이드	Wedbush	Neutral → Outperform
2019-04-12	개시	Guggenheim	Neutral
2019-02-07	업그레이드	Citigroup	Sell → Buy
2019-02-07	다운그레이드	Wedbush	Outperform → Neutral
2019-02-06	업그레이드	Raymond James	Underperform → Mkt Perform
2019-02-04	다운그레이드	Citigroup	Neutral → Sell
2018-12-10	다운그레이드	Raymond James	Outperform → Underperform
2018-09-10	재개	BTIG Research	Buy
2018-05-31	개시	Evercore ISI	Outperform
2018-03-05	개시	H.C. Wainwright	Buy
2017-03-31	개시	Raymond James	Outperform

모두보기

Macrogenics Inc 주식(MGNX)의 최신 뉴스

MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call

GlobeNewswire Inc.

MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate

Benzinga

Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Benzinga

The Latest Analyst Ratings For Macrogenics

Benzinga

Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session

Benzinga

MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures

GlobeNewswire Inc.

Macrogenics Inc (MGNX) 재무 분석

Macrogenics Inc (MGNX) 매출 2024

Macrogenics Inc (MGNX) 순이익 2024

Macrogenics Inc (MGNX) 현금흐름 2024

Macrogenics Inc (MGNX) 주당 순이익 2024